机译:肝硬化患者的头孢唑酮/抑菌剂治疗药物监测:影响药代动力学/药效学靶达的潜在因素
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Infect Dept Xian Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Pharm Xian 710061 Shaanxi Peoples R China;
cefoperazone; sulbactam; classification and regression tree; liver cirrhosis; pharmacokinetic; pharmacodynamic; therapeutic drug monitoring;
机译:肝硬化患者的头孢唑酮/抑菌剂治疗药物监测:影响药代动力学/药效学靶达的潜在因素
机译:治疗药物监测哌啶/塔沙漠酰胺的连续输注显着改善了危重患者的药代动力学靶标:从四年的临床经验中的回顾性分析
机译:治疗药物监测引导的哌啶/塔沙漠酰胺的连续输注显着改善了危重病患者的药代动力学目标达成:四年临床经验的回顾性分析
机译:马术竞赛中药物滥用和治疗药物的药代动力学和药代动力学模型
机译:临床药代动力学模拟/建模,作为特殊患者人群中治疗药物监测和剂量调整的工具。
机译:用于批评性患者的模型优化的氟康唑剂量选择改善了早期药物动力学目标达到的药物动力学靶量而不需要治疗药物监测
机译:肝硬化患者的头孢噻唑酮/抑菌剂治疗药物监测:影响药代动力学/药物动力学目标达到的潜在因素